JPMorgan upgrades Meta to Overweight, lifts price target to $820

2 min read
JPMorgan upgrades Meta to Overweight, lifts price target to $820
PrimeXBT Editorial Team
Reviewed by PrimeXBT

Topics in article

JPMorgan upgraded Meta Platforms from Neutral to Overweight and raised its price target to $820 from $640, citing progress on frontier AI models and new products beyond advertising. The bank also projects higher capital spending through 2028, which it expects to pressure free cash flow even as Meta's core business keeps generating strong cash.

JPMorgan upgraded Meta Platforms (NASDAQ:META) from Neutral to Overweight on Thursday and raised its price target to $820 from $640. The firm said Meta shares are up 20% from recent lows but still down 1% year-to-date, versus the S&P 500's 12% gain.

Frontier models and new AI products

JPMorgan said Meta is in the early stages of releasing frontier models and AI-driven products beyond advertising, including the Muse AI agent and Meta Model API access. The Muse AI agent reached as high as number three in the U.S. app store on its second day, with early usage running at 10 times that of training cohorts.

JPMorgan said monetization is not the near-term priority for Muse, but the firm noted opportunities across a take-rate model and subscriptions. The bank added that Meta's goal in summer 2025 was to deliver models at the frontier within a year, which JPMorgan believes the company has essentially achieved.

Capex set to climb, pressuring free cash flow

JPMorgan projects 2027 capital expenditures of $243 billion, up 70%, and 2028 capex of $284 billion, up 17%, both well above consensus. The firm anticipates free cash flow pressure in the range of negative $65 billion to $70 billion in each of those years.

That projection contrasts with Meta's current cash generation, which produced $41 billion in levered free cash flow over the last twelve months. Meta has indicated it will maximize compute capacity in 2026 and 2027, with more flexibility in 2028 and beyond.

Source: Investing.com

Trading involves risk.

Most traded markets

XAU / USD
-0.22% 4,391.83
BRENT
+0.9% 104.321
BTC / USD
-1.63% 78,039.3
EUR / USD
+0.03% 1.16356
USTEC
-0.25% 29,351.85
GOOG
-0.03% 328.36
View all markets

Author

PrimeXBT
Our Editorial Team consists of leading experts with a proven record in the fields of trading, cryptocurrencies, blockchain and finance. We thoroughly research the sources of information in order to provide readers with quality content that serves edu...
Read author’s articles
Alert Triangle Risk Disclaimer
Disclaimer: Some past publications may be outdated. We recommend following our news to stay up to date with the latest information. For any questions, feel free to contact our support team via the chat below.
The content provided here is for informational purposes only. It is not intended as personal investment advice and does not constitute a solicitation or invitation to engage in any financial transactions, investments, or related activities. Past performance is not a reliable indicator of future results.
The financial products offered by the Company are complex and come with a high risk of losing money rapidly due to leverage. These products may not be suitable for all investors. Before engaging, you should consider whether you understand how these leveraged products work and whether you can afford the high risk of losing your money.
The Company does not accept clients from the Restricted Jurisdictions as indicated in our website/ T&C. Some services or products may not be available in your jurisdiction.
The applicable legal entity and its respective products and services depend on the client’s country of residence and the entity with which the client has established a contractual relationship during registration.

Today in markets

Browse Stock News

Register Now

Trading involves risk

Get started in minutes

Our clients love how fast and simple our sign-up is. It takes just a few minutes to get started!

Get Started Get Started
Get started in minutes

Need Help?

Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.